Protocols
for Children with Brain Tumors
02-C-0193:
A Phase II Study of Pegylated Interferon Alfa-2b (Peg-Intron‘)
in Children with Diffuse Pontine Gliomas
Principal Investigator: Dr. Katherine Warren
05-C-0132:
A Phase I Trial of CC-5013 (Lenalidomide) in Pediatric Patients
with Recurrent or Refractory Primary CNS Tumors
Principal Investigator: Dr. Katherine Warren
06-C-0089:
Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric
Patients with Recurrent or Progressive High-Grade Gliomas and Recurrent
or Progressive Brainstem Tumors
Principal Investigator: Dr. Katherine Warren
Last Updated:
:July 26, 2006
NCI
Home Page|| NIH Home Page
© 2002-2003, Pediatric Oncology Branch, Center for Cancer Research,
National Cancer Institute
|
![[Division of Clinical Sciences]](images/CCRpd_logo.gif){kind=logo}